, The Green Pennies Stock Report: 10/17/17

Pages

Tuesday, October 17, 2017

Medical Innovation Holdings, Inc. Forward-Looking Analysis

Print Friendly and PDF

Business Information:

Medical Innovation Holdings, Inc.
Ticker: MIHI
0.623 a/o October 16, 2017
Down -0.017 points or -2.66%

Source: Yahoo Finance
https://finance.yahoo.com/quote/MIHI/

Market Value: $2443419 a/o October 16, 2017
Authorized Shares: 500000000 a/o September 9, 2016
Outstanding Shares: 39235022 a/o July 31, 2017

Source: OTCMarkets
http://www.otcmarkets.com/stock/MIHI/profile

5805 State Bridge Road Suite G-328
Duluth, GA 30097
Phone Number: 1(866)883-3793
Website: http://medicalinnovationholdings.com

Fundamental Analysis:

Medical Innovation Holdings, Inc. focuses on establishing a multi-disciplinary medical specialist provider/practice network to serve rural patient population through telemedicine program. Its integrated practice management system provides electronic medical records/electronic health records, patient scheduling, real time insurance verification, billing, video conferencing, and various systems in an end to end technology platform coupled with the components of a telehealth delivery system. The company is based in Duluth, Georgia.

Through our wholly owned subsidiary, 3Point Care, we provide personalized high-tech high-touch telemedicine encounters pairing our virtual health specialty doctors with traditional primary doctors utilizing nextgen virtual health technologies in order to connect a patient with a multi-disciplinary specialty clinical healthcare practice. Through our other companies and relationships we offer Affordable Care Organization (ACO) support, wellness and prevention, lab analysis and lab services, and remote diagnostic monitoring.

Source: Yahoo Finance - Statistics   and   OTCMarkets
https://finance.yahoo.com/quote/MIHI/profile?p=MIHI     and     http://www.otcmarkets.com/stock/MIHI/profile

Businesses Management:

Mr. Arturo Sanchez, CEO  & Director
Dr. Christopher J. W. B. Legett, Chief Medical Officer

Statistics:

Market Cap (Intraday):24.41M
Trailing P/E: -27.09
Price/Sales: 0
52-Week Change: -36
52-Week High: 3.99
52-Week Low: 0
50-Day Moving Average: 0.562
200-Day Moving Average: 1.259
Average Volume (3 Month): 25.17k
Average Volume (10 Day): 79.15k

Source: Yahoo Finance - Statistics
https://finance.yahoo.com/quote/MIHI/key-statistics?p=MIHI

Quarterly Report Published on October 4, 2017:

First, let's look at the condensed balance sheet for Medical Innovation Holdings, Inc.. We see that the company has $30692.00 in total assets, $1350630.00 in total liabilities, $1319938.00 in shareholders' deficit, and $30692.00 in total liabilities and shareholders' deficit.

Next, let's look at the condensed statements of operations (income statement). Looking solely at the numbers for the three month period ending on July 31, 2017, we see that the company has $0.00 in revenue. The cost of revenue is at $0.00, thus making the gross $0.00. Now we factor in the operating expenses with total expenses being $179203.00, leaving MIHI with an operating loss of $-179203.00. MIHI also has $170779.00 in other expenses, leaving the company with a net loss of $-349982.00.

Income Statement Analysis:

$0.00                    (Sales, Revenue)
- ($0.00)                    (Cost of Sales)
=$0.00                   (Gross Profit)

$0.00                  (Gross Profit)
- ($179203.00)                   (Other Selling, General, and Administrative Expenses)
=$-179203.00                   (Loss from Operations)

$-179203.00                   (Loss from Operations)
- ($170779.00)                   (Total Other Income/Expenses)
=$-349982.00                    (Net loss)

Income Statement Summary:
$0.00         
-($0.00)           in Cost of Sales
-($179203.00)           in Administrative Expenses
-($170779.00)           in Other Expenses
____________________
$-349982.00           in Leftover Revenue

Source: OTCMarkets - Filings
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12311779

Market Analysis:

The world's major regions are expected to see health care spending increases ranging from 2.4 percent to 7.5 percent between 2015 and 2020. Also, lack of access to basic health care services and variations in care quality are persistent problems in many of the world's regions.

Source: Deloitte
https://www2.deloitte.com/global/en/pages/life-sciences-and-healthcare/articles/global-health-care-sector-outlook.html

News:

Medical Innovation Holdings, Inc., a company that was the first to focus on providing specialty telemedicine/telehealth services to patients in rural underserved areas, today announced that the Company CEO was a guest on the nationally syndicated The Big Show on Monday 14, 2017.

Medical Innovation Holdings, Inc. today announces the appointment of Kevin Swint to the role of Chief Operating Officer (COO), effective immediately. With more than 25 years of experience in operations and senior leadership experience in the health and wellness industry, Swint is a natural fit for MIHI's mission to provide specialty telemedicine/telehealth services to patients in rural underserved areas.

Medical Innovation Holdings, Inc. today announces the launch of Telemedicos USA, a Spanish-Language health care platform positioned to address the needs of the 58 million Hispanics in the United States.

Source: Marketwired & PR Newswire
https://finance.yahoo.com/quote/MIHI?p=MIHI

Technical Analysis:

In a timescale of 3 years, MIHI has spent most of its time between the 0.8121 and 0.499 region with some significant spikes along the way. The stock increased on 9/12/2016 from a pps (price per share) of ~0.0551 to ~3.12 on 3/20/2017. The stock stayed around this level until it decreased from 2.8095 on 4/24/2017, to 0.566 on 6/19/2017. After this change, the stock had a relative high of 3.12 on 3/20/201. Currently, the stock price is climbing1 to a price of 0.623 on October 16, 2017.

Looking at resistance lines (a price where the stock has trouble pushing above/below), we see 0.7095 being the next point of resistance. From here, 0.7813 will likely be the next point of resistance. On the downside, the lower resistance line is at 0.5131. The current Bollinger Bands show a range between 0.4918 and 0.6835. Current RSI (or Relative Strength Index) is at 53.42 or overbought. Also, I see that selling volume is currently overtaking buying volume.

Source: TDAmeritrades ThinkorSwim Platform
tdameritrade.com

Social Analysis:

For social analysis, we look at what investors are posting about the stock on sites like IHUB and Yahoo Money. Many different people are discussing the stock on this board currently. The message board seems active in that multiple people are posting frequently in the forums section. 7 people currently have MIHI added to their My Stocks tab. Currently, the community sentiment is bullish. We would rate this as a plus for the stock!

Source: InvestorHub
https://investorshub.advfn.com/Medical-Innovation-Holdings-Inc-MIHI-9360/

Stock Ranking (BETA):

Positives

3 Year Stock Direction is Positive
1 Year Stock Direction is Positive
1 Week Stock Direction is Positive
Actively Being Traded
Listed as Verified
Currently Trading on the OTCPink Sheets
Marked as Having Current Information
Has a Reasonable Number of Outstanding Shares
Actively Giving Press Releases To Its Investors
The Quarterly Report For Last Quarter Is Currently Available
The Last 4 Quarterly Reports Are Currently Available
The Annual Quarterly Report Is Currently Available
The Companies Forum Is Active
Many Investors Are Posting About The Stock Daily
Current Community Sentiment Towards The Stock is Positive


Negatives

3 Month Stock Direction is Negative
1 Week Stock Direction is Negative
Not Operating Profitable
No Growth Over The Last 3 Months
No Growth Over The Last 12 Months


Other

1 Month Stock Direction is Constant
The Company Is Neither Buying Up Nor Diluting Their Shares
The Company Is Not Currently In The Process Of Any Form Of Merger That We Know Of
The Company is Not Currently Giving Out Dividends

Stock Ranking: C Rank



Forward-Looking Analysis:

Medical Innovation Holdings, Inc. currently has their financial information available to their investors as well as supplying them with recent press releases as to what the company is currently doing. The financial statement shows that the company has nothing in revenue and has been running at a loss for a while. This should be a concern to investors. Looking at the companies’ technical, the company seems to be pretty consolidated at the moment by staying between the 0.7022 range and the 0.4900 range for a while. Considering the nature of consolidation, good news could cause a move higher where poor move will trigger a move lower. Considering that the stock has been bouncing between that range, it might be possible to flip the company for a nice profit. It also might be possible to long the company until it goes back up to the dollar range. My concern though would be that the company currently isn't showing anything under revenue. If the company maybe had something to show for revenue, this would definitely add more security to your investment. This is definitely a stock to watch!

What do you think? We would love to hear your opinions in the comments below!

Disclosure:

I wrote this article myself, and it expresses my own opinion. I have no business relationship with any company whose stock is mentioned in this article. I also will not be holding shares in the company in the next two weeks of this articles posting.

I have no positions in any stocks mentioned and have no plans to initiate any positions within the next 72 hours.

If you wish to copy this article, you're allowed to do so only when you link back to my article.

Lastly, if you have anything that you would like to add to this article, please write in the comments section below. Be sure to give me a like and subscribe if you like the article! Thanks For Reading!


Print Friendly and PDF

ALR Technologies, Inc. Forward-Looking Analysis

Print Friendly and PDF


Business Information:

ALR Technologies, Inc.
Ticker: ALRT
0.0549  a/o  October 16, 2017
UP 0.0279 points or 103.33%

Source: Yahoo Finance
https://finance.yahoo.com/quote/ALRT/

Market Value: $13328507 a/o October 16, 2017
Authorized Shares: 500000000 a/o February 10, 2015
Outstanding Shares: 242777909 a/o February 10, 2015

Source: OTCMarkets
http://www.otcmarkets.com/stock/ALRT/profile

7400 Beaufont Springs Drive
Richmond, VA 23225
Phone Number: 1(804)554-3500
Website: http://www.alrt.com

Fundamental Analysis:

ALR Technologies is a medical device company providing remote monitoring and care facilitation for patients with diabetes. ALRT has developed the FDA-cleared Health-e-Connect System which uploads the data from blood glucose meters onto a secure website where clinicians and Diabetes Care Facilitators can better monitor and coordinate the care of diabetes patients. ALRT's system goal is to assist patients to adhere to their care plan, improving the quality of diabetes care and making such care more cost effective to providers.

The companys product includes Health-e-Connect System, which consists of a communications software platform that enables health professionals to monitor the health progress relating to patients with diabetes. It focuses on marketing its products primarily to the providers of health insurance; and the providers of disease and case management services, including the home care industry.

Source: Yahoo Finance - Profile   and   OTCMarkets
https://finance.yahoo.com/quote/ALRT/profile?p=ALRT     and     http://www.otcmarkets.com/stock/ALRT/profile

Businesses Management:

Mr. Sidney S. Chan, Chairman, Chief Executive Officer (CEO), Chief Financial Officer, Treasurer, and Sec.
Dr. Kent Stoneking Pharm. D., CDE, Director of Diabetes Care Facilitation
Mr. Andrew Klips, Exec.
Mr. Glen Reyes, Exec.
Ms. Barbara Dubiel, Consultant

Statistics:

Market Cap (Intraday):13.33M
Trailing P/E: -2.11
Price/Sales: 0
52-Week Change: 2150
52-Week High: 0.1479
52-Week Low: 0
50-Day Moving Average: 0.0312
200-Day Moving Average: 0.009
Average Volume (3 Month): 1.92M
Average Volume (10 Day): 1.77M

Source: Yahoo Finance - Statistics
https://finance.yahoo.com/quote/ALRT/key-statistics?p=ALRT

Quarterly Report Not Available

Market Analysis:

A new report by Visiongain predicts the world market for diabetes medications will reach $55.3bn in 2017. The antidiabetic medicines industry generated $35.6bn in 2012, and its revenues will show strong growth to 2023.

Source: VisionGain
https://www.visiongain.com/Press_Release/405/Diabetes-drugs-market-will-reach-55-3bn-in-2017-with-further-growth-to-2023-predicts-Visiongain-in-new-report

News:

Following the recent FDA clearance of the Company's Insulin Dose Adjustment feature, ALR Technologies Inc. is releasing details of its patent pending Predictive A1C innovation added to the ALRT Diabetes Management System.

On September 18, 2017, the United States Food and Drug Administration (FDA) granted clearance to ALR Technologies Inc. for an innovative insulin dose adjustment feature of the ALRT diabetes management system.

The United States Food and Drug Administration (FDA) has granted clearance to ALR Technologies Inc. for an innovative insulin does adjustment feature of the ALRT diabetes management system.

Source: Marketwired
https://finance.yahoo.com/quote/ALRT?p=ALRT

Technical Analysis:

In a timescale of 3 years, ALRT has spent most of its time between the 0.0721 and 0.0276 region with some significant spikes along the way. The stock increased on 9/12/2017 from a pps (price per share) of ~0.0021 to ~0.141 on 9/19/17. The stock stayed around this level until it decreased from 0.141 on 9/19/17, to 0.0476 on 9/22/2017. After this change, the stock had a relative high of 0.141 on 9/19/2017. Currently, the stock price is climbing1 to a price of 0.0549 on 10/16/2017.

Looking at resistance lines (a price where the stock has trouble pushing above/below), we see 0.0619 being the next point of resistance. From here, 0.0785 will likely be the next point of resistance. On the downside, the lower resistance line is at 0.0482. The current Bollinger Bands show a range between 0.0254 and 0.0549. Current RSI (or Relative Strength Index) is at 70.05 or overbought. Also, I see that buying volume is currently overtaking selling volume.

Source: TDAmeritrades ThinkorSwim Platform
tdameritrade.com

Social Analysis:

For social analysis, we look at what investors are posting about the stock on sites like IHUB and Yahoo Money. Many different people are discussing the stock on this board currently. The message board seems active in that multiple people are posting frequently in the forums section. 46 people currently have ALRT added to their My Stocks tab. Currently, the community sentiment is bullish. We would rate this as a plus for the stock!

Source: InvestorHub
https://investorshub.advfn.com/ALR-Technologies-ALRT-16188/?NextStart=6142

Stock Ranking (BETA):

Positives

3 Year Stock Direction is Positive
1 Year Stock Direction is Positive
3 Month Stock Direction is Positive
1 Week Stock Direction is Positive
Actively Being Traded
Currently Trading on the OTCPink Sheets
Has a Reasonable Number of Outstanding Shares
Actively Giving Press Releases To Its Investors
The Companies Forum Is Active
Many Investors Are Posting About The Stock Daily
46 People Have This Stock Added To Their My Stocks Tab On IHUB
Current Community Sentiment Towards The Stock is Positive


Negatives

1 Week Stock Direction is Negative
No Information Available About The Stock
Not Operating Profitable
No Growth Over The Last 3 Months
No Growth Over The Last 12 Months
The Quarterly Report For Last Quarter Is Currently Unavailable
The Last 4 Quarterly Reports Are Currently Unavailable
The Annual Quarterly Report Is Currently Unavailable


Other

1 Month Stock Direction is Constant
The Company Is Neither Buying Up Nor Diluting Their Shares
The Company Is Not Currently In The Process Of Any Form Of Merger That We Know Of
The Company is Not Currently Giving Out Dividends

Stock Ranking: D Rank



Forward-Looking Analysis:

ALR Technologies, Inc. currently doesn't have any recent quarterly reports available for investors. On the other hand, the company is new releasing new press releases for investors talking about new products that have been cleared by the FDA. This is definitely a positive for the company, though the fact that the company doesn't have any financial information available should be seen as a reason for concern. Of course, this is an appropriate risk considering this is pennyland. Looking at the technical for the company, the stock seems to be consolidating at its new range between 0.0625 and 0.0262. In time, I expect this to tighten more until more news is released, with which might prop the stock up higher. Considering the constant movements between the high and the low, it is possible to flip the stock to make a nice profit. You could also long this stock, though it would be a safer investment post financial information being released. This is definitely a stock to watch for future growth!

What do you think? We would love to hear your opinions in the comments below!

Disclosure:

I wrote this article myself, and it expresses my own opinion. I have no business relationship with any company whose stock is mentioned in this article. I also will not be holding shares in the company in the next two weeks of this articles posting.

I have no positions in any stocks mentioned and have no plans to initiate any positions within the next 72 hours.

If you wish to copy this article, you're allowed to do so only when you link back to my article.

Lastly, if you have anything that you would like to add to this article, please write in the comments section below. Be sure to give me a like and subscribe if you like the article! Thanks For Reading!


Print Friendly and PDF

Unilava Corporation Forward-Looking Analysis

Print Friendly and PDF


Business Information:

Unilava Corporation
Ticker: UNLA
0.004  a/o  10/16/2017
UP 0.0031 points or 344.44%

Source: Yahoo Finance
https://finance.yahoo.com/quote/UNLA/

Market Value: $448212 a/o October 16, 2017
Authorized Shares: 120000000 a/o October 16, 2017
Outstanding Shares: 112052888 a/o October 16, 2017

Source: OTCMarkets
http://www.otcmarkets.com/stock/UNLA/profile

71 Stevenson Street Suite 430
San Francisco, CA 94110
Phone Number: 1(415)321-3490
Website: http://www.unilava.com

Fundamental Analysis:

Unilava and its subsidiaries provide diversified communication services. The company engages in the development, design, and marketing of communication services and advertising offerings. The company is also licensed to provide long distance services in 41 states and local phone services in 11 states. Through its 40 carrier-grade microwave wireless broadband infrastructure and broadband Internet access partners, the company offers mobile and high-definition IP-hosted voice services to residential customers and small-to-medium enterprises.

 The company delivers small business a comprehensive and integrated suite of fee-based online and mobile advertising and web services. In addition, the company operates its enterprise social networking portal for its members to connect and interact, utilizing an array of services including video chat, video email, e-fax, VoIP, and conference calling.

Source: OTCMarkets
http://www.otcmarkets.com/stock/UNLA/profile

Businesses Management:

Baldwin Yung, Chief Executive Officer (CEO), and President
Glen Goglia, COO
Boaz Yung, EVP, Bus. Dev.
Chris Chen, EVP, Sales

Statistics:

Market Cap (Intraday):400.2k
Trailing P/E: -0.36
Price/Sales: 0.19
52-Week Change: 0
52-Week High: 0.007
52-Week Low: 0
50-Day Moving Average: 0.001
200-Day Moving Average: 0.001
Average Volume (3 Month): 14.86k
Average Volume (10 Day): 3.35k

Source: Yahoo Finance - Statistics
https://finance.yahoo.com/quote/UNLA/key-statistics?p=UNLA

*This company currently isn’t releasing any quarterly reports or press releases for investors.

Technical Analysis:

In a timescale of 3 years, UNLA has spent most of its time between the 0.005 and 0.0009 region with some significant spikes along the way. The stock increased on 10/10/2017 from a pps (price per share) of ~0.0009 to ~0.005 on 10/16/2017. The stock stayed around this level until it decreased from 0.005 on 10/16/2017, to 0.0039 on 10/16/2017. After this change, the stock had a relative high of 0.005 on 10/16/2017. Currently, the stock price is falling2 to a price of 0.004 on 10/16/2017.

Looking at resistance lines (a price where the stock has trouble pushing above/below), we see 0.005 being the next point of resistance. From here, 0.0064 will likely be the next point of resistance. On the downside, the lower resistance line is at 0.0039. The current Bollinger Bands show a range between 0.0007 and 0.0032. Current RSI (or Relative Strength Index) is at 79.14 or oversold. Also, I see that buying volume is currently overtaking selling volume.

Source: TDAmeritrade ThinkorSwim
tdameritrade.com

Social Analysis:

For social analysis, we look at what investors are posting about the stock on sites like IHUB and Yahoo Money. About 8 are currently talking about the stock over the period of a day. The message board doesn't seem to be very active with spotty posts here and there. 7 people currently have UNLA added to their My Stocks tab. Currently, the community sentiment is bullish. We would rate this as a plus for the stock!

Source: InvestorHub
https://investorshub.advfn.com/Unilava-Corporation-UNLA-15666/

Stock Ranking (BETA):

Positives

3 Month Stock Direction is Positive
1 Month Stock Direction is Positive
1 Week Stock Direction is Positive
Actively Being Traded
Currently Trading on the OTCPink Sheets
Current Community Sentiment towards the Stock is Positive


Negatives

3 Year Stock Direction is Negative
1 Week Stock Direction is Negative
No Information Available About the Stock
Large (Unreasonable) Number of Outstanding Shares
Not Operating Profitable
Not Actively Giving Press Releases to Shareholders
No Growth over the Last 3 Months
No Growth over the Last 12 Months
The Quarterly Report for Last Quarter Is Currently Unavailable
The Last 4 Quarterly Reports Are Currently Unavailable
The Annual Quarterly Report Is Currently Unavailable
The Companies IHUB Forum Is Currently Not Very Active


Other

1 Year Stock Direction is Constant
The Company Is neither Buying Up nor Diluting Their Shares
The Company Is Not Currently In The Process Of Any Form of Merger That We Know Of
The Company is Not Currently Giving out Dividends

Stock Ranking: F Rank



Forward-Looking Analysis:

Unilava Corporation currently doesn't have any financial information available for investors to look through (recent). Also, the company isn't releasing any new press releases for investors. This has earned them a stop sign on their OTCMarkets page with it being marked as Pink No Information. While the company has had a very nice increase in pps today, I expect that price to correct soon. Until the company starts releasing information for investors, this company will have an obvious risk that goes along with it when investing. At the current pps, you probably won't be able to flip it. Also, there's no reason to long the stock as there is no fundamental data available.

What do you think? We would love to hear your opinions in the comments below!

Disclosure:

I wrote this article myself, and it expresses my own opinion. I have no business relationship with any company whose stock is mentioned in this article. I also will not be holding shares in the company in the next two weeks of this articles posting.

I have no positions in any stocks mentioned and have no plans to initiate any positions within the next 72 hours.

If you wish to copy this article, you're allowed to do so only when you link back to my article.

Lastly, if you have anything that you would like to add to this article, please write in the comments section below. Be sure to give me a like and subscribe if you like the article! Thanks For Reading!


Print Friendly and PDF